Molecular Diagnosis of Usher Syndrome

Application of Two Different Next Generation Sequencing-Based Procedures

Danilo Licastro, Margherita Mutarelli, Ivana Peluso, Kornelia Neveling, Nienke Wieskamp, Rossella Rispoli, Diego Vozzi, Emmanouil Athanasakis, Angela D'Eustacchio, Mariateresa Pizzo, Francesca D'Amico, Carmela Ziviello, Francesca Simonelli, Antonella Fabretto, Hans Scheffer, Paolo Gasparini, Sandro Banfi, Vincenzo Nigro

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Usher syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by visual and hearing impairments. Clinically, it is subdivided into three subclasses with nine genes identified so far. In the present study, we investigated whether the currently available Next Generation Sequencing (NGS) technologies are already suitable for molecular diagnostics of USH. We analyzed a total of 12 patients, most of which were negative for previously described mutations in known USH genes upon primer extension-based microarray genotyping. We enriched the NGS template either by whole exome capture or by Long-PCR of the known USH genes. The main NGS sequencing platforms were used: SOLiD for whole exome sequencing, Illumina (Genome Analyzer II) and Roche 454 (GS FLX) for the Long-PCR sequencing. Long-PCR targeting was more efficient with up to 94% of USH gene regions displaying an overall coverage higher than 25×, whereas whole exome sequencing yielded a similar coverage for only 50% of those regions. Overall this integrated analysis led to the identification of 11 novel sequence variations in USH genes (2 homozygous and 9 heterozygous) out of 18 detected. However, at least two cases were not genetically solved. Our result highlights the current limitations in the diagnostic use of NGS for USH patients. The limit for whole exome sequencing is linked to the need of a strong coverage and to the correct interpretation of sequence variations with a non obvious, pathogenic role, whereas the targeted approach suffers from the high genetic heterogeneity of USH that may be also caused by the presence of additional causative genes yet to be identified.

Original languageEnglish
Article numbere43799
JournalPLoS One
Volume7
Issue number8
DOIs
Publication statusPublished - 29 Aug 2012
Externally publishedYes

Fingerprint

Usher Syndromes
Genes
Exome
application coverage
genes
Polymerase Chain Reaction
hearing
Audition
genotyping
Microarrays
Genetic Heterogeneity
Molecular Pathology
Vision Disorders
Hearing Loss
mutation
genome
Genome
Technology
Mutation

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Licastro, D., Mutarelli, M., Peluso, I., Neveling, K., Wieskamp, N., Rispoli, R., ... Nigro, V. (2012). Molecular Diagnosis of Usher Syndrome: Application of Two Different Next Generation Sequencing-Based Procedures. PLoS One, 7(8), [e43799]. https://doi.org/10.1371/journal.pone.0043799

Molecular Diagnosis of Usher Syndrome : Application of Two Different Next Generation Sequencing-Based Procedures. / Licastro, Danilo; Mutarelli, Margherita; Peluso, Ivana; Neveling, Kornelia; Wieskamp, Nienke; Rispoli, Rossella; Vozzi, Diego; Athanasakis, Emmanouil; D'Eustacchio, Angela; Pizzo, Mariateresa; D'Amico, Francesca; Ziviello, Carmela; Simonelli, Francesca; Fabretto, Antonella; Scheffer, Hans; Gasparini, Paolo; Banfi, Sandro; Nigro, Vincenzo.

In: PLoS One, Vol. 7, No. 8, e43799, 29.08.2012.

Research output: Contribution to journalArticle

Licastro, D, Mutarelli, M, Peluso, I, Neveling, K, Wieskamp, N, Rispoli, R, Vozzi, D, Athanasakis, E, D'Eustacchio, A, Pizzo, M, D'Amico, F, Ziviello, C, Simonelli, F, Fabretto, A, Scheffer, H, Gasparini, P, Banfi, S & Nigro, V 2012, 'Molecular Diagnosis of Usher Syndrome: Application of Two Different Next Generation Sequencing-Based Procedures', PLoS One, vol. 7, no. 8, e43799. https://doi.org/10.1371/journal.pone.0043799
Licastro, Danilo ; Mutarelli, Margherita ; Peluso, Ivana ; Neveling, Kornelia ; Wieskamp, Nienke ; Rispoli, Rossella ; Vozzi, Diego ; Athanasakis, Emmanouil ; D'Eustacchio, Angela ; Pizzo, Mariateresa ; D'Amico, Francesca ; Ziviello, Carmela ; Simonelli, Francesca ; Fabretto, Antonella ; Scheffer, Hans ; Gasparini, Paolo ; Banfi, Sandro ; Nigro, Vincenzo. / Molecular Diagnosis of Usher Syndrome : Application of Two Different Next Generation Sequencing-Based Procedures. In: PLoS One. 2012 ; Vol. 7, No. 8.
@article{d6df9e62fde24a86870d5037eb5796ce,
title = "Molecular Diagnosis of Usher Syndrome: Application of Two Different Next Generation Sequencing-Based Procedures",
abstract = "Usher syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by visual and hearing impairments. Clinically, it is subdivided into three subclasses with nine genes identified so far. In the present study, we investigated whether the currently available Next Generation Sequencing (NGS) technologies are already suitable for molecular diagnostics of USH. We analyzed a total of 12 patients, most of which were negative for previously described mutations in known USH genes upon primer extension-based microarray genotyping. We enriched the NGS template either by whole exome capture or by Long-PCR of the known USH genes. The main NGS sequencing platforms were used: SOLiD for whole exome sequencing, Illumina (Genome Analyzer II) and Roche 454 (GS FLX) for the Long-PCR sequencing. Long-PCR targeting was more efficient with up to 94{\%} of USH gene regions displaying an overall coverage higher than 25×, whereas whole exome sequencing yielded a similar coverage for only 50{\%} of those regions. Overall this integrated analysis led to the identification of 11 novel sequence variations in USH genes (2 homozygous and 9 heterozygous) out of 18 detected. However, at least two cases were not genetically solved. Our result highlights the current limitations in the diagnostic use of NGS for USH patients. The limit for whole exome sequencing is linked to the need of a strong coverage and to the correct interpretation of sequence variations with a non obvious, pathogenic role, whereas the targeted approach suffers from the high genetic heterogeneity of USH that may be also caused by the presence of additional causative genes yet to be identified.",
author = "Danilo Licastro and Margherita Mutarelli and Ivana Peluso and Kornelia Neveling and Nienke Wieskamp and Rossella Rispoli and Diego Vozzi and Emmanouil Athanasakis and Angela D'Eustacchio and Mariateresa Pizzo and Francesca D'Amico and Carmela Ziviello and Francesca Simonelli and Antonella Fabretto and Hans Scheffer and Paolo Gasparini and Sandro Banfi and Vincenzo Nigro",
year = "2012",
month = "8",
day = "29",
doi = "10.1371/journal.pone.0043799",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Molecular Diagnosis of Usher Syndrome

T2 - Application of Two Different Next Generation Sequencing-Based Procedures

AU - Licastro, Danilo

AU - Mutarelli, Margherita

AU - Peluso, Ivana

AU - Neveling, Kornelia

AU - Wieskamp, Nienke

AU - Rispoli, Rossella

AU - Vozzi, Diego

AU - Athanasakis, Emmanouil

AU - D'Eustacchio, Angela

AU - Pizzo, Mariateresa

AU - D'Amico, Francesca

AU - Ziviello, Carmela

AU - Simonelli, Francesca

AU - Fabretto, Antonella

AU - Scheffer, Hans

AU - Gasparini, Paolo

AU - Banfi, Sandro

AU - Nigro, Vincenzo

PY - 2012/8/29

Y1 - 2012/8/29

N2 - Usher syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by visual and hearing impairments. Clinically, it is subdivided into three subclasses with nine genes identified so far. In the present study, we investigated whether the currently available Next Generation Sequencing (NGS) technologies are already suitable for molecular diagnostics of USH. We analyzed a total of 12 patients, most of which were negative for previously described mutations in known USH genes upon primer extension-based microarray genotyping. We enriched the NGS template either by whole exome capture or by Long-PCR of the known USH genes. The main NGS sequencing platforms were used: SOLiD for whole exome sequencing, Illumina (Genome Analyzer II) and Roche 454 (GS FLX) for the Long-PCR sequencing. Long-PCR targeting was more efficient with up to 94% of USH gene regions displaying an overall coverage higher than 25×, whereas whole exome sequencing yielded a similar coverage for only 50% of those regions. Overall this integrated analysis led to the identification of 11 novel sequence variations in USH genes (2 homozygous and 9 heterozygous) out of 18 detected. However, at least two cases were not genetically solved. Our result highlights the current limitations in the diagnostic use of NGS for USH patients. The limit for whole exome sequencing is linked to the need of a strong coverage and to the correct interpretation of sequence variations with a non obvious, pathogenic role, whereas the targeted approach suffers from the high genetic heterogeneity of USH that may be also caused by the presence of additional causative genes yet to be identified.

AB - Usher syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by visual and hearing impairments. Clinically, it is subdivided into three subclasses with nine genes identified so far. In the present study, we investigated whether the currently available Next Generation Sequencing (NGS) technologies are already suitable for molecular diagnostics of USH. We analyzed a total of 12 patients, most of which were negative for previously described mutations in known USH genes upon primer extension-based microarray genotyping. We enriched the NGS template either by whole exome capture or by Long-PCR of the known USH genes. The main NGS sequencing platforms were used: SOLiD for whole exome sequencing, Illumina (Genome Analyzer II) and Roche 454 (GS FLX) for the Long-PCR sequencing. Long-PCR targeting was more efficient with up to 94% of USH gene regions displaying an overall coverage higher than 25×, whereas whole exome sequencing yielded a similar coverage for only 50% of those regions. Overall this integrated analysis led to the identification of 11 novel sequence variations in USH genes (2 homozygous and 9 heterozygous) out of 18 detected. However, at least two cases were not genetically solved. Our result highlights the current limitations in the diagnostic use of NGS for USH patients. The limit for whole exome sequencing is linked to the need of a strong coverage and to the correct interpretation of sequence variations with a non obvious, pathogenic role, whereas the targeted approach suffers from the high genetic heterogeneity of USH that may be also caused by the presence of additional causative genes yet to be identified.

UR - http://www.scopus.com/inward/record.url?scp=84865585969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865585969&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0043799

DO - 10.1371/journal.pone.0043799

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e43799

ER -